Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.40 |
| ▸ | FLT4 | P35916 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7237402 | 0.89 | DPP4 (0.49) | LMNAKMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL7228137 | 0.86 | ALDH1A1 (0.36) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| Choline SCHEMBL7228133 | 0.86 | GFER (0.33) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL6603300 | 0.85 | LMNA (0.55) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL8942049 | 0.84 | TOP1 (0.40) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL7227506 | 0.83 | LMNA (0.47) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL7228568 | 0.82 | ALDH1A1 (0.45) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL9094359 | 0.82 | ALDH1A1 (0.55) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL9097124 | 0.81 | ALDH1A1 (0.54) | LMNAKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL9786221 | 0.81 | ALDH1A1 (0.47) | LMNAKMT2AMEN1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6548506-B2 | 1-substituted,3-carboxy,7-fluoro,8-disubstituted amino-1,4-dihydrobenzo(b)(1,8)naphthyridin-4-ones; Useful as antimicrobial agents; topical antibiotic for wounds | AVENTIS PHARMA S.A. (FR) | 2003-04-15 | — | — | US | disclosed |
| US-20020037891-A1 | Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them | AVENTIS PHARMA S.A. (FR) | 2002-03-28 | — | — | US | disclosed |
| EP-1140932-A1 | 1,8-BENZONAPHTHYRIDINE DERIVATIVES | Aventis Pharma S.A. (FR) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037467-A1 | 1,8-BENZONAPHTHYRIDINE DERIVATIVES | AVENTIS PHARMA S.A. (FR) | 2000-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037891-A1 | Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them | ABCB11, NDUFA9, NDUFC1 | LMNA 1363/4885KMT2A 4345/4885MEN1 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.